Pub Date : 2020-12-31DOI: 10.36519/10.36519/idcm.2020.0027
M. Aydın, Esra Nur Karadogan, A. Kadanalı
Objective: We aimed to investigate the risk factors for surgical site infections (SSI) and the effectiveness of prophylactic antibiotic use. Methods: The demographic characteristics, comorbidities, and microbiological examinations of patients diagnosed with SSI who had a cholecystectomy, vaginal hysterectomy, knee prosthesis, hip prosthesis, and gastric surgery between January the 1st, 2014 and December the 31st, 2019 were retrospectively analysed. The diagnosis of healthcare-associated infections and SSI was based on the Centers for Disease Control and Prevention criteria. Results: We detected Gram-negative bacteria in 30% of knee prosthesis infections (60% carbapenem-resistant), 60% of hip prosthesis infections (39% carbapenem-resistant), 36% of vaginal hysterectomy (no carbapenem resistance), 50% of cholecystectomy (no carbapenem resistance), and 20% of gastric surgery (no carbapenem resistance). Staphylococci were the causative agents in 30% of knee prosthesis infections (30% methicillin-resistant) and 20% of hip prosthesis infections (38% methicillin-resistant). Conclusion: We detected multidrug resistance in microorganisms isolated from knee and hip replacement infections. Antibiotic resistance is a big problem, and antibiotic prophylaxis is insufficient to prevent SSI. Doctors should follow up with the patient who underwent surgery closely and take microbiological samples to select appropriate antibiotics when SSI develops.
{"title":"Effectiveness of Surgical Prophylaxis Where the Antibiotic Resistance is High","authors":"M. Aydın, Esra Nur Karadogan, A. Kadanalı","doi":"10.36519/10.36519/idcm.2020.0027","DOIUrl":"https://doi.org/10.36519/10.36519/idcm.2020.0027","url":null,"abstract":"Objective: We aimed to investigate the risk factors for surgical site infections (SSI) and the effectiveness of prophylactic antibiotic use. Methods: The demographic characteristics, comorbidities, and microbiological examinations of patients diagnosed with SSI who had a cholecystectomy, vaginal hysterectomy, knee prosthesis, hip prosthesis, and gastric surgery between January the 1st, 2014 and December the 31st, 2019 were retrospectively analysed. The diagnosis of healthcare-associated infections and SSI was based on the Centers for Disease Control and Prevention criteria. Results: We detected Gram-negative bacteria in 30% of knee prosthesis infections (60% carbapenem-resistant), 60% of hip prosthesis infections (39% carbapenem-resistant), 36% of vaginal hysterectomy (no carbapenem resistance), 50% of cholecystectomy (no carbapenem resistance), and 20% of gastric surgery (no carbapenem resistance). Staphylococci were the causative agents in 30% of knee prosthesis infections (30% methicillin-resistant) and 20% of hip prosthesis infections (38% methicillin-resistant). Conclusion: We detected multidrug resistance in microorganisms isolated from knee and hip replacement infections. Antibiotic resistance is a big problem, and antibiotic prophylaxis is insufficient to prevent SSI. Doctors should follow up with the patient who underwent surgery closely and take microbiological samples to select appropriate antibiotics when SSI develops.","PeriodicalId":11964,"journal":{"name":"European Journal of Clinical Microbiology and Infectious Diseases","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85713802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
G. Cengiz Seval, S. Bozdağ, İ. Akdemir Kalkan, S. Koçak Toprak, P. Topçuoğlu, A. Azap, O. Arslan
COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been declared as a global pandemic and worldwide confirmed cases are currently approaching 76 million. And so far, thrombocytopenia has been observed in 5% of hospitalized COVID-19 patients and 8% of those in intensive care unit (1,2). Although the decrease in platelet counts was mild, confirmation of immune etiology has to be confirmed in those with severe thrombocytopenia (<20 x 109/L) or a sudden decrease in the platelet count >50% over 24-48 hours (3). The role of viral infections in the exacerbation of immune thrombocytopenic thrombocytopenia (ITP) has been revealed previously. We hereby report a patient who had exacerbation of ITP and was subsequently found to be COVID-19 positive.
{"title":"Relapse of Immune Thrombocytopenic Purpura in a Patient With COVID-19","authors":"G. Cengiz Seval, S. Bozdağ, İ. Akdemir Kalkan, S. Koçak Toprak, P. Topçuoğlu, A. Azap, O. Arslan","doi":"10.36519/idcm.2020.0026","DOIUrl":"https://doi.org/10.36519/idcm.2020.0026","url":null,"abstract":"COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been declared as a global pandemic and worldwide confirmed cases are currently approaching 76 million. And so far, thrombocytopenia has been observed in 5% of hospitalized COVID-19 patients and 8% of those in intensive care unit (1,2). Although the decrease in platelet counts was mild, confirmation of immune etiology has to be confirmed in those with severe thrombocytopenia (<20 x 109/L) or a sudden decrease in the platelet count >50% over 24-48 hours (3). The role of viral infections in the exacerbation of immune thrombocytopenic thrombocytopenia (ITP) has been revealed previously. We hereby report a patient who had exacerbation of ITP and was subsequently found to be COVID-19 positive.","PeriodicalId":11964,"journal":{"name":"European Journal of Clinical Microbiology and Infectious Diseases","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85502566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Duygu Ozkaya, Sevgi Bilen Ayhan, Çağla Yazar, Ozgen Nahya, Pınar Kılıcdagı, A. Azap
Objective: We aimed to describe pathogenic contamination on healthcare workers’ cellular phones, detect factors associated with contamination, and demonstrate whether there was a link between cell phone contamination and subsequent healthcare-associated infections. Methods: The study was conducted in a 2000-bed tertiary care university hospital in Ankara. A total of 631 healthcare workers (HCWs) from several departments willing to participate were included in the study. Bacterial cultures were taken from each cell phone via rotating a sterile swab moistened with sterile physiological saline solution over both sides of the phone surface and cover. Samples were taken to the bacteriology laboratory within one hour and streaked onto 5% sheep blood agar. Isolated microorganisms were identified with conventional methods. Results: All 631 cell phones investigated had positive cultures; forty-four (6.05%) were pathogenic microorganisms. Drug resistance was not detected among pathogenic bacteria. As determined by univariate analysis, using flip phone cover (P = 0.022), a professional experience of fewer than five years (P = 0.049), having cleaned the phone within the last 48 hours (P = 0.030), and working in a medical ward (P = 0.022) were significantly associated with pathogen contamination on the devices. Multivariate analysis with logistic regression revealed that using flip cover is the only factor associated with pathogen contamination on cell phones (P=0.035). Pathogen contamination on smartphones (7.7%) seemed to be higher than on mobile phones (5.2%) (P=0.263). Conclusion: Pathogen contamination on smartphones was higher than on mobile phones but did not reach statistical significance. Using flip cover covers on cellular phones increases contamination rates. We could not show any HAI occurred by the bacteria isolated from cell phones, but health care workers should pay attention to this issue.
{"title":"Bacterial Contamination of Cellular Phones: Are Mobile Phones Safer than Smart Phones?","authors":"Duygu Ozkaya, Sevgi Bilen Ayhan, Çağla Yazar, Ozgen Nahya, Pınar Kılıcdagı, A. Azap","doi":"10.36519/idcm.2020.0032","DOIUrl":"https://doi.org/10.36519/idcm.2020.0032","url":null,"abstract":"Objective: We aimed to describe pathogenic contamination on healthcare workers’ cellular phones, detect factors associated with contamination, and demonstrate whether there was a link between cell phone contamination and subsequent healthcare-associated infections. Methods: The study was conducted in a 2000-bed tertiary care university hospital in Ankara. A total of 631 healthcare workers (HCWs) from several departments willing to participate were included in the study. Bacterial cultures were taken from each cell phone via rotating a sterile swab moistened with sterile physiological saline solution over both sides of the phone surface and cover. Samples were taken to the bacteriology laboratory within one hour and streaked onto 5% sheep blood agar. Isolated microorganisms were identified with conventional methods. Results: All 631 cell phones investigated had positive cultures; forty-four (6.05%) were pathogenic microorganisms. Drug resistance was not detected among pathogenic bacteria. As determined by univariate analysis, using flip phone cover (P = 0.022), a professional experience of fewer than five years (P = 0.049), having cleaned the phone within the last 48 hours (P = 0.030), and working in a medical ward (P = 0.022) were significantly associated with pathogen contamination on the devices. Multivariate analysis with logistic regression revealed that using flip cover is the only factor associated with pathogen contamination on cell phones (P=0.035). Pathogen contamination on smartphones (7.7%) seemed to be higher than on mobile phones (5.2%) (P=0.263). Conclusion: Pathogen contamination on smartphones was higher than on mobile phones but did not reach statistical significance. Using flip cover covers on cellular phones increases contamination rates. We could not show any HAI occurred by the bacteria isolated from cell phones, but health care workers should pay attention to this issue.","PeriodicalId":11964,"journal":{"name":"European Journal of Clinical Microbiology and Infectious Diseases","volume":"18 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84384757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
G. Aygun, O. Kayhan, Fatouma Moustapha Houssein, S. Urkmez, A. Kurt, B. Mete
The original trademark name of remdesivir with proven and approved efficacy developed by Gilead is Veklury®. Veklury® is licenced in over 50 countries around the world, including the United States, European Union, Japan, Canada, Australia. Veklury® has not yet been licenced by the Ministry of Health in Turkey. Gilead supplied 17 378 vials of Veklury® to the Health of Ministry of Turkey free of charge. However, Gilead announced that illegal products which are likely to contain remdesivir have been entered our country and sold on the black market (3).
{"title":"Contaminated Generic Non-approved Remdesivir Vials: New Risk in Treatment of COVID-19","authors":"G. Aygun, O. Kayhan, Fatouma Moustapha Houssein, S. Urkmez, A. Kurt, B. Mete","doi":"10.36519/idcm.2020.0031","DOIUrl":"https://doi.org/10.36519/idcm.2020.0031","url":null,"abstract":"The original trademark name of remdesivir with proven and approved efficacy developed by Gilead is Veklury®. Veklury® is licenced in over 50 countries around the world, including the United States, European Union, Japan, Canada, Australia. Veklury® has not yet been licenced by the Ministry of Health in Turkey. Gilead supplied 17 378 vials of Veklury® to the Health of Ministry of Turkey free of charge. However, Gilead announced that illegal products which are likely to contain remdesivir have been entered our country and sold on the black market (3).","PeriodicalId":11964,"journal":{"name":"European Journal of Clinical Microbiology and Infectious Diseases","volume":"31 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90593813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This work is licensed under a Creative Commons Attribution-Non Commercial 4.0 International License. ABSTRACT A 19-year-old woman with a history of tuberculosis (TB) in her family presented to the infectious disease clinic of our hospital with right flank pain, nausea, vomiting, a 10kg weight loss, and decreased urine volume for the past two months. Empirical anti-TB treatment was initiated due to her family history of tuberculosis, a positive purified protein derivative skin test, and the presence of a nodule in the posterobasal segment of the lung upon F18-FDG PET/CT. We aimed to present the complete regression of a pelvic mass lesion after empirical tuberculosis treatment that was visualized on follow-up F18-FDG PET/CT imaging and discuss its contribution to the literature. F18-FDG PET/CT imaging followup may offer an invaluable resource for monitoring extrapulmonary involvement of TBinfected patients. The F18-FDG PET/CT imaging method may also contribute to the followup of granulomatous and inflammatory diseases.
{"title":"Complete Pelvic Mass Regression Following Tuberculosis Treatment as Indicated by F18-FDG PET/CT","authors":"E. Akbulut, M. Tatoğlu, F. Arslan","doi":"10.36519/idcm.2020.0025","DOIUrl":"https://doi.org/10.36519/idcm.2020.0025","url":null,"abstract":"This work is licensed under a Creative Commons Attribution-Non Commercial 4.0 International License. ABSTRACT A 19-year-old woman with a history of tuberculosis (TB) in her family presented to the infectious disease clinic of our hospital with right flank pain, nausea, vomiting, a 10kg weight loss, and decreased urine volume for the past two months. Empirical anti-TB treatment was initiated due to her family history of tuberculosis, a positive purified protein derivative skin test, and the presence of a nodule in the posterobasal segment of the lung upon F18-FDG PET/CT. We aimed to present the complete regression of a pelvic mass lesion after empirical tuberculosis treatment that was visualized on follow-up F18-FDG PET/CT imaging and discuss its contribution to the literature. F18-FDG PET/CT imaging followup may offer an invaluable resource for monitoring extrapulmonary involvement of TBinfected patients. The F18-FDG PET/CT imaging method may also contribute to the followup of granulomatous and inflammatory diseases.","PeriodicalId":11964,"journal":{"name":"European Journal of Clinical Microbiology and Infectious Diseases","volume":"196 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72904259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-12-02DOI: 10.21203/rs.3.rs-114148/v1
Özlem Doğan, Hacer Aktürk, Berna Özer, Elif Nurtop, Cansel Vatansever, Gülin Özcan, Aydın Çelikyurt, F. Khalilova, A. Okan, S. Incir, C. Saçkesen, Ö. Ergönül
We report infectivity of adult and pediatric COVID-19 patients in presence of viral shedding and anti-SARS-CoV-2 antibody response A total of 408 consequent samples from eleven adult and five pediatric patients with SARS-CoV-2 infection were included. The samples every second day from saliva, nasopharynx, feces, serum, urine, tear were studied by RT-PCR and viral culture. Anti-SARS-CoV-2 antibodies were measured. The median duration of RNA shedding in all specimens was 7(2-15) days in adults and 5(3-19) days in children. The median duration from onset of symptoms to admission was three days.The viral RNA was positive in 44.7 % of the nasopharynx and 37.6% of saliva samples up 16 days in adults and 19 days in chldren. The latest viral culture positivity was detected on day 8 of symptoms in nasopharynx. The viral RNA was found in 6.1% of feces, 4.4% ofserum, 4.3 % of tear, 2.9% of urine. The earliest seroconversion was the 7th day for adults and 8th day for children. Atthe 14th day, total antibody positivity was 78% in adults, and 80% in children. After seroconversion, the viral RNA was still detected in the nasopharynx and saliva of three patients, however, the infectious virus was not present. Earlier hospital admission could be associated with shorter SARS-CoV-2 RNA shedding. The infectivity of patient is very low after 8 days of symptoms. The risk of fecal-oral transmission is very low, and strict hand hygiene measures could be preventive. The positive antibody test result could be used as a discharge criterion.
{"title":"Infectivity of Adult and Pediatric COVID-19 Patients","authors":"Özlem Doğan, Hacer Aktürk, Berna Özer, Elif Nurtop, Cansel Vatansever, Gülin Özcan, Aydın Çelikyurt, F. Khalilova, A. Okan, S. Incir, C. Saçkesen, Ö. Ergönül","doi":"10.21203/rs.3.rs-114148/v1","DOIUrl":"https://doi.org/10.21203/rs.3.rs-114148/v1","url":null,"abstract":"\u0000 We report infectivity of adult and pediatric COVID-19 patients in presence of viral shedding and anti-SARS-CoV-2 antibody response A total of 408 consequent samples from eleven adult and five pediatric patients with SARS-CoV-2 infection were included. The samples every second day from saliva, nasopharynx, feces, serum, urine, tear were studied by RT-PCR and viral culture. Anti-SARS-CoV-2 antibodies were measured. The median duration of RNA shedding in all specimens was 7(2-15) days in adults and 5(3-19) days in children. The median duration from onset of symptoms to admission was three days.The viral RNA was positive in 44.7 % of the nasopharynx and 37.6% of saliva samples up 16 days in adults and 19 days in chldren. The latest viral culture positivity was detected on day 8 of symptoms in nasopharynx. The viral RNA was found in 6.1% of feces, 4.4% ofserum, 4.3 % of tear, 2.9% of urine. The earliest seroconversion was the 7th day for adults and 8th day for children. Atthe 14th day, total antibody positivity was 78% in adults, and 80% in children. After seroconversion, the viral RNA was still detected in the nasopharynx and saliva of three patients, however, the infectious virus was not present. Earlier hospital admission could be associated with shorter SARS-CoV-2 RNA shedding. The infectivity of patient is very low after 8 days of symptoms. The risk of fecal-oral transmission is very low, and strict hand hygiene measures could be preventive. The positive antibody test result could be used as a discharge criterion.","PeriodicalId":11964,"journal":{"name":"European Journal of Clinical Microbiology and Infectious Diseases","volume":"C-31 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84445918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-11-20DOI: 10.36519/10.36519/idcm.2020.0017
Z. Karakoç, A. Basel, Yesim Koçak, Binnur Pınarbaşı Şimşek, S. Tuğrul, Figen Akın
Norwegian scabies, which is a highly contagious variant of scabies, is a common parasitic infestation in elderly persons living in care homes. Clinical symptoms may be different in this patient group (slow onset and insidious progression, often without intense itching) with the addition of comorbid conditions, such as dementia and neurological diseases. Healthcare workers should be aware of this form of scabies, which is more common in elderly and cognitively impaired patients. Early diagnosis can be made easily by a microscopic examination of skin lesions. Isolation precautions are important measures to prevent outbreaks. The treatment includes keratolytic agents besides topical and oral scabicides because of the high mite burden and hyperkeratotic lesions of the crusted scabies. In this study, we reported on a case who had resided in a geriatric care home. The patient was diagnosed with crusted scabies and died in our intensive care unit with pneumonia.
{"title":"Crusted (Norwegian) Scabies in a Malnourished Geriatric Patient with Dementia","authors":"Z. Karakoç, A. Basel, Yesim Koçak, Binnur Pınarbaşı Şimşek, S. Tuğrul, Figen Akın","doi":"10.36519/10.36519/idcm.2020.0017","DOIUrl":"https://doi.org/10.36519/10.36519/idcm.2020.0017","url":null,"abstract":"Norwegian scabies, which is a highly contagious variant of scabies, is a common parasitic infestation in elderly persons living in care homes. Clinical symptoms may be different in this patient group (slow onset and insidious progression, often without intense itching) with the addition of comorbid conditions, such as dementia and neurological diseases. Healthcare workers should be aware of this form of scabies, which is more common in elderly and cognitively impaired patients. Early diagnosis can be made easily by a microscopic examination of skin lesions. Isolation precautions are important measures to prevent outbreaks. The treatment includes keratolytic agents besides topical and oral scabicides because of the high mite burden and hyperkeratotic lesions of the crusted scabies. In this study, we reported on a case who had resided in a geriatric care home. The patient was diagnosed with crusted scabies and died in our intensive care unit with pneumonia.","PeriodicalId":11964,"journal":{"name":"European Journal of Clinical Microbiology and Infectious Diseases","volume":"177 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73162157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Candidiasis is an opportunistic infection caused by yeasts of the genus Candida . In recent years, there has been a great deal of interest in Candida infections because of the resurgence of diseases that weaken the immune system and the widespread use of immunosuppressive chemotherapy. The choice of diagnosis method and identification of the Candida species at the origin of the infection is essential for better management of patients, because the infectious mechanisms and the sensitivity to antifungal agents can vary from one Candida species to another. This review provides an overview of the Candida species involved, clinical aspects, diagnostic methods, and treatments available against candidiasis encountered in human pathology.
{"title":"Candida Infections: Clinical Features, Diagnosis and Treatment","authors":"S. B. Tamo","doi":"10.36519/idcm.2020.0006","DOIUrl":"https://doi.org/10.36519/idcm.2020.0006","url":null,"abstract":"Candidiasis is an opportunistic infection caused by yeasts of the genus Candida . In recent years, there has been a great deal of interest in Candida infections because of the resurgence of diseases that weaken the immune system and the widespread use of immunosuppressive chemotherapy. The choice of diagnosis method and identification of the Candida species at the origin of the infection is essential for better management of patients, because the infectious mechanisms and the sensitivity to antifungal agents can vary from one Candida species to another. This review provides an overview of the Candida species involved, clinical aspects, diagnostic methods, and treatments available against candidiasis encountered in human pathology.","PeriodicalId":11964,"journal":{"name":"European Journal of Clinical Microbiology and Infectious Diseases","volume":"2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78694625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. Tammaro, G. Adebanjo, C. Solé-Lleonart, J. Rello
1 NESMOS Dermatology Department, Sapienza University of Rome, Azienda Ospedaliera Sant’Andrea, Rome, Italy 2 Hospital Universitari de Vic, Barcelona, Spain 3 Centro de Investigación Biomedica en Red de Enfermedades Respiratorias (CIBERES), Instituto Salud Carlos III Madrid, Spain 4 Clinical Research/Epidemiology in Pneumonia and Sepsis (CRIPS), Vall d’Hebron Institute of Research (VHIR), Barcelona, Spain 5 Clinical Research, CHU Nîmes, Université Montpellier-Nîmes, Nîmes, France
1 NESMOS Dermatology Department,罗马Sapienza University of、Azienda Ospedaliera圣'Andrea,罗马,意大利2维克、巴塞罗那、西班牙3 Universitari医院研究中心网络Biomedica呼吸道疾病(CIBERES马德里卡洛斯三世)、卫生研究所,西班牙4 Clinical Research / Epidemiology in Pneumonia and败血症(CRIPS)、Vall d 'Hebron Institute of Research (VHIR)、巴塞罗那、西班牙5 Clinical Research,楚Nî学月Montpellier-Nî月,Nî月,France
{"title":"An Exceptional Use of Two Gloves Technique During COVID-19 Pandemic","authors":"A. Tammaro, G. Adebanjo, C. Solé-Lleonart, J. Rello","doi":"10.36519/idcm.2020.0004","DOIUrl":"https://doi.org/10.36519/idcm.2020.0004","url":null,"abstract":"1 NESMOS Dermatology Department, Sapienza University of Rome, Azienda Ospedaliera Sant’Andrea, Rome, Italy 2 Hospital Universitari de Vic, Barcelona, Spain 3 Centro de Investigación Biomedica en Red de Enfermedades Respiratorias (CIBERES), Instituto Salud Carlos III Madrid, Spain 4 Clinical Research/Epidemiology in Pneumonia and Sepsis (CRIPS), Vall d’Hebron Institute of Research (VHIR), Barcelona, Spain 5 Clinical Research, CHU Nîmes, Université Montpellier-Nîmes, Nîmes, France","PeriodicalId":11964,"journal":{"name":"European Journal of Clinical Microbiology and Infectious Diseases","volume":"6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85285163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Footprints of the 21st Century Pandemic: Coronavirus History","authors":"Y. Beşli","doi":"10.36519/idcm.2020.0016","DOIUrl":"https://doi.org/10.36519/idcm.2020.0016","url":null,"abstract":"","PeriodicalId":11964,"journal":{"name":"European Journal of Clinical Microbiology and Infectious Diseases","volume":"31 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75751566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：